Day Time Sinus

Product NDC
55315-099
11-digit product format
553150099
Labeler code
55315
Product ID
55315-099_26e63f3d-5446-4118-96aa-5d674600b94f
Type
HUMAN OTC DRUG
Nonproprietary name
Acetaminophen and Phenylephrine Hydrochloride
Dosage form
CAPSULE, LIQUID FILLED
Route
ORAL
Labeler
Freds Inc
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2012-08-15
Marketing end
2024-01-12
Substance
ACETAMINOPHEN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
325 mg/1; mg/1
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct55315-099DDiscontinued by firm2026-10-05
excluded packagepackage55315-09955315-099-16DDiscontinued by firm2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage55315-099-16d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage55315-099-16f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage55315-099-162ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage55315-099-16a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage55315-099-16cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage55315-099-16cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage55315-099-16302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage55315-099-16ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage55315-099-160efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage55315-099-16ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage55315-099-16367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage55315-099-16557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
55315-099-162021-10-19C16284748780-1ba0f9c33-3501-a910-e053-dadaa90a0b85Drug Facts
55315-099-162021-01-29C16284748780-1ba0f9c33-3501-a910-e053-dadaa90a0b85Drug Facts

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ACETAMINOPHENACTIVE INGREDIENT362O9ITL9DDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
ACETAMINOPHENACTIVE MOIETY362O9ITL9DDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8DAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
GELATININACTIVE INGREDIENT2G86QN327LDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
GLYCERININACTIVE INGREDIENTPDC6A3C0OXDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1ADAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
POVIDONESINACTIVE INGREDIENTFZ989GH94EDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3DAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
SORBITANINACTIVE INGREDIENT6O92ICV9RUDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
SORBITOLINACTIVE INGREDIENT506T60A25RDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2
WATERINACTIVE INGREDIENT059QF0KO0RDAY TIME SINUS PAIN RELIEVER, NASAL DECONGESTANT (ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE) CAPSULE, LIQUID FILLED [FREDS INC]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
55315-099-16553150099162 BLISTER PACK in 1 CARTON (55315-099-16) > 8 CAPSULE, LIQUID FILLED in 1 BLISTER PACK2 blister pack2012-08-152024-01-12NoNoCurrent